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ABSTRACT 
The incidence of Kamala is very common due to life style, food habits and 
sanitation (water pollution and contaminated food) etc. as there is no 
conventional therapy available in modern sciences, so people are having 
affinity towards Ayurveda. This makes it necessary to work out in this 
issue, by providing safe effective and affordable treatment. Ayurveda 
provides cure of the disease on the basis of proper flow of Pittadosha in 
Koshtha in case of Shakhashrit kamala. Pittashamak, Yakrut uttejak, 
Yakrut shodhana to normal flow of bile from liver in case of Bahupitta 
kamala. Hyperbilirubinaemia is a condition where there is yellow 
appearance of skin, sclera and mucous membrane resulting from an 
increase bilirubin concentration in the body fluids, mostly explained as 
jaundice which resemble the sign “Haridratwakanakhannana, Haridra-
Netra-mutra ”explained in the Kamala in Charak chikitsa sthana 
(16/35and126). The present study was planned to evaluate the effect of 
Vasadi kashaya on Kamala w. s. r. to Hyperbilirubinemia. Total 30 
patients attending the OPD and IPD of R. A. Podar Ayurvedic Hospital 
Mumbai were randomly selected. After classical formulation Vasadi 
Kashaya was given for 3 weeks to these patients. Significant 
improvement was observed in the symptoms of Kamala. 
 
INTRODUCTION 
Ayurveda is system of traditional medicine 
native to India and practiced in other parts of the 
world as a form of alternative medicine. In Sanskrit 
the word Ayurveda comprises “Ayur” means life and 
“Veda” means Science. Ayurveda is the science of 
life that deals not only with welfare and pleasure 
but also with hazards and sorrows of life. It 
emphasizes on preventive aspect as well as curative 
treatment. Kamala is one of the prominent 
conditions which attract attention of modern day. 
As it is seen frequently in various forms today 
irrespective of age, sex, socioeconomical condition, 
education etc, Kamala is mentioned in Ayurvedic 
texts mainly in Brihat-trayi as 16th chapter of 
Charak samhita chikitsa sthana, 44th chapter of 
Sushrut Uttarsthana, 13th chapter of Nidansthana, 
16th chapter of Ashtang Hridaya, Chikitsasthana. In 
all the above mentioned texts, the description of 
Kamala came along with Pandu Roga. [1-4]  
 Hyperbilirubinamia is a common liver 
disorder. It is found in all socioeconomically classes 
of the society. The liver disorders have remained a 
challenge to medical profession. Many of them 
ultimately lead to irreversible changes.[5][6][7][8] 
Hyperbilirubinemia is a condition where there is 
yellow appearance of skin, sclera and mucous 
membrane resulting from an increase bilirubin 
concentration in the body fluids, mostly explained 
as jaundice which resemble the sign “Haridratwak- 
anakhannana, Haridra-netra-mutra” explained in 
the Kamala in Charak Chikitsasthana. (16/35& 126) 
 Today there is a tremendous change in 
life style. This type of life style ultimately reflects 
upon the liver. Increased tendency to take open-air 
food, fast-food, cold drinks etc., give an excessive 
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load on the liver. Negligence about self-cleanliness, 
water pollution, and contaminated food are the 
main causative factors for viral infection. This leads 
to various liver disorders like viral hepatitis, 
amoebic hepatitis, liver cirrhosis etc. Out of which 
Sankramak Kamala (viral hepatitis) is facing 
problem showing the signs and symptoms of 
Kamala. 
 ‘Kamala’ is a Vyadhi of Raktavaha strotas in 
which Rakta is vitiated by Doshas especially Pitta. 
As per this concept Raktavaha Mulasthana Dushti 
i.e. Yakrut dushti takes place. This disturbs the 
Swasthya and develops different symptoms such as 
‘Nakh-Netra-Mutra-Twak Peetata’ although 
“Anutsaha” desire to do nothing. Despite of the fact, 
that most of the viral diseases are self-limiting in 
nature, number of patients of viral hepatitis has 
been observed to be shifting from sub-clinical 
infection to rapid progressive chronic liver disease 
with liver cirrhosis and even Hepatocellular 
carcinoma. 
 In fact, in spite of a spectacular advance in 
modern medicine numerous problems still remain, 
especially in the management of liver diseases. Till 
today there is no satisfactory medicine. All modern 
medicines are artificially prepared and chemical in 
nature. These drugs are metabolized and detoxified 
in the liver. Thus most of the drugs are considered 
as hepatotoxic. Naturally inadequacies available in 
medicines give view towards the Ayurveda. The 
results of Ayurvedic preparations on the liver 
diseases are very outstanding. In Ayurvedic 
literature many herbs and Kalpas are described for 
Kamala. There are many preparations available in 
Ayurveda.[9,10] 
 While treating kamala main line of 
treatment is Virechan, to bring proper flow of 
Pittadosha in Koshtha in case of Shakhashrit 
Kamala, Pittashamak, Yakrut uttejak, Yakrut 
shodhan to normal flow of bile from liver in case of 
Bahupitta Kamala. 
 The selected drug was Vasadi kashaya from 
Bhaishjya Ratnavali. Its contents are 1) Vasa Twak 
2) Guduchi 3) Kutaki 4) Neem Twak and 5) 
Chirayta.[11] 
 Decoction with Madhu (Honey) follow 
the Chikitsasutra siddhant of Kamala through Rasa, 
Virya, Vipaka etc. As well as drugs are easily 
available and cost effective. Number of patients 
suffering from Kamala is quite high. The unbearable 
“Haridra-Mutra-Netra-Twakata” of Kamala have 
limited results of other drugs. Although special 
reference of Bhaishajya Ratnawali has explained 
Vasadi Kashaya.[12] 
 As described in Granthas the 
conventional treatment of Kamala is to use pungent, 
sharp, hot, salty and sour substances to remove the 
obstruction of Kapha mainly in Shakhashrit Kamala. 
But the Vasadi Kashaya is mainly Tikta and Katu 
Raspradhan Kalpa and Virechak dravya, 
Yakrutottejak, Yakrut Shodhan having property 
which is also remove obstruction of Kapha without 
doing Pittaprakopa and does Rasayana Karma also 
in both types of Kamala. So in spite of using 
conventional therapy we selected the Kalpa, which 
is working according to basic principle of Chikitsa 
Siddhant.[13,14] 
MATERIAL AND METHODS 
A) Study: Prospective, open Randomized study. 
B) Subject recruitment: Patient will be selected 
from OPD and IPD of College and Hospital.  
C) Name of study center: O.P.D. and I.P.D. of 
Kayachikitsa Department.  
Drug Name: Vasaadi Kashaya 
Contents: 1)Vasaa Twak 2) Guduchi 3) Neem Twak 
4) Chirayta 5) Kutki, all in equal Parts. 
Preparation of drug: Preparation of Vasaadi 
Kashaya as per scientific, authentic. Preparation 
method of Vasaadi Kashaya will be done according 
to Sharangadhar Samhita. 
Method of preparation of Kwatha: One part of 
Bharad Choorna (all ingredients taken in same 
quantity) will be taken and 16 part of water will be 
added in it. Then the whole mixture will be boiled 
up to 1/8th of it remains. Then it will be filtered. 
Dose: 30 ml Twice Daily 
Anupan: Madhu 5 ml.  
Time of administration: During meal of morning 
and night (Saman kala). 
Diet: Specified diet, Mugdala khichadi, Laghu 
aahaar as per indicated Shuka Varga, Peya, Vilepi 
and Jawar Roti. Shimbi Varga, Mudga yush (green 
gram), Kulatth yush (horsegram), Masur yush 
(lentil) Shak Varga –Patol, Shushka mulak (radish), 
Dugdh Varga–Takra, Phala Varga- Dadim 
(pomegranate), Manuka (Dried black Grapes). 
D) Follow up: Will be maintained weekly. Follow 
up for 21 days. 
E) Inclusion Criteria 
1. Age -12 to 60 yrs. 
2. Sex- Male and Female 
3. Patient with signs and symptom of Kamala. 
4. Patient having serum bilirubin level above 
1.3mg/dl. 
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F) Exclusion Criteria 
1. Patient above 60 yrs and below 12 yrs age. 
2. Pregnancy and Lactating mother. 
3. Cases of liver abscess, liver cirrhosis, HBsAg 
positive and known case HIV Positive. 
4. Patients having malignancy. 
5. Patients in acute alcohol withdrawal state, 
intoxication Hepatic encephalopathy. 
6. Serum bilirubin level more than 20mg/dl. 
7. Psychotic patients. 
8. Hyperbilirubinaemia due to congenital cause, 
Drug toxicity, AKT. 
9. Surgical obstructive pathology. 
G) Clinical Examination: Complete clinical 
examination from the point of view of Kamala will 
be done to diagnose and assess the development of 
patient’s disease condition. 
H) Diagnostic Criteria 
1. Person with classical symptoms of Kamala.  
2. Serum bilirubin level above 1.3mg/dl.  
I) Investigations: 1. Liver Function Test –SGPT 
(ALT), SGOT (AST), Serum bilirubin level before and 
after study. 
2. Urine for – Bile salt and Bile pigment. Before and 
after study. 
3. Serum protein, Albumin, Alkaline Phosphate– at 
the start and end of study.  
4. USG Abdomen-if needed. 
5. Other investigations CBC, ESR, RFT, Lipid profile, 
BSL - Before and After study. HIV, VDRL, HBsAg. 
Subjective assessment 
1 Netra Peetata  
 Absent 0 
 Mild 1 
 Can be seen in Sunlight 2 
 Can be seen without Sunlight also  3 
2 Peeta Mutrata  
 Normal urine colour 0 
 Yellowish coloured urine 1 
 Dark yellow coloured urine 2 
 High coloured urine 3 
3 Yakrita Vrudhi  
 Absent 0 
 1 finger 1 
 2 finger 2 
 3 finger ++ 3 
4 Jvara  
 Absent 0 
 Temp.99-100 degree F 1 
 Temp.100-102 degree F 2 
 Temp. above 102 degree F 3 
5 Chhardi (Vomiting)  
 No vomiting 0 
 Less than 3 episodes 1 
 3-6 episodes per day 2 
 More than 6 episodes per day 3 
6 Sadana (Anganam Anutsaha)  
 No weakness 0 
 Weakness not disturbing daily routine work 1 
 Weakness disturbing daily routine work 2 
 Weakness required complete bed rest 3 
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7 Daha  
 Absent 0 
 Daha tends Trishna (thirst) 1 
 Daha tends Murcha (unconsciousness) 2 
 Daha tends Pralapa (irrelevant talk) 3 
8 Twaka Peetata  
 Absent 0 
 Mild 1 
 Can be seen in Sunlight 2 
 Can be seen without Sunlight also 3 
9 Avipaka  
 Normal stool (motions) 0 
 Heaviness in the Abdomen 1 
 Heaviness with sticky/ hard stool 2 
 Heaviness with constipation more than 2 days 3 
10 Udarshool  
 Absent 0 
 Mild 1 
 Moderate 2 
 Severe 3 
11 Aruchi (Anorexia)  
 Normal 0 
 Less desire to eat 1 
 Less desire to eat with nausea 2 
 Less desire to eat with severe nausea 3 
 Observations and Results 
Table 1: Showing effect of therapy on symptom score of 30 patients 
 Characters  B.T.  A.T. Difference % of relief 
 1 Netra Peetata  49  9  40 81.63% 
 2 Peeta Mutrata  50  12  38 76% 
 3 Yakrit vruddhi  21  5  16 76.19% 
 4 Jwara  21  2  19 90.47% 
 5 Chhardi  29  3  26 89.65% 
 6 Sadan  34  6  28 82.35% 
 7 Daha  25  7  18 72% 
 8 Twaka Peetata  21  7  14 66.66% 
 9 Avipaka  48  13  35 72.91% 
 10 Udarshool  24  7  17 70.83% 
 11 Aruchi  41  18  23 56.09% 
 Average score  33  8.09  24.90 75.88% 
Table 2: Showing Wilcoxon match paired sign rank test on subjective parameters 
S.No. Symptoms  Mean SD SEd W N  P 
 1 Netrapeetata BT 1.633 0.7649 0.1396 435 29 <0.0001 
AT 0.3000 0.4661 0.08510 
Dif. 1.333 0.5467 0.09981 
 2 Peetmutrata BT 1.667 0.7581 0.1384 406 28 <0.0001 
AT 0.4000 0.5632 0.1028 
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Dif. 1.267 0.5833 0.1065 
 3 Yakrita Vruddhi BT 0.7000 0.7497 0.1369 120 15 <0.0001 
AT 0.1667 0.3790 0.06920 
Dif 0.5333 0.5713 0.1043 
 4 Jwara BT 0.7000 0.6513 0.1189 171 18 <0.0001 
AT 0.0667 0.2537 0.04632 
Dif 0.6333 0.5561 0.1015 
 5 Chhardi BT 0.9667 0.7184 0.1312 253 22 <0.0001 
AT 0.1000 0.3051 0.05571 
Dif 0.8667 0.6288 0.1148 
 6 Sadan BT 1.133 0.6814 0.1244 325 25 <0.0001 
AT 0.2000 0.4068 0.07428 
Dif 0.9333 0.5208 0.09509 
 7 Daha BT 0.8333 0.3790 0.06920 171 18 <0.0001 
AT 0.2333 0.4302 0.07854 
Dif 0.6000 0.4983 0.09097 
 8 Twaka Peetata BT 0.7000 0.9879 0.1804 66 11 <0.0001 
AT 0.2333 0.5040 0.09202 
Dif 0.4667 0.6814 0.1244 
 9 Avipaka BT 1.600 0.6747 0.1232 435 29 <0.0001 
AT 0.4333 0.6261 0.1143 
Dif 1.167 0.4611 0.08419 
10 Udarshool BT 0.8000 0.7611 0.1390 120 15 <0.0001 
AT 0.2333 0.4302 0.07854 
Dif 0.5667 0.6261 0.1143 
11 Aruchi BT 1.367 0.6149 0.1123 210 20 <0.0001 
AT 0.6000 0.5632 0.1028 
Dif 0.7667 0.6261 0.1143 
Paired t-test on objective parameters 
Table 3: Showing effects of therapy on primary objectives variables 
Investigation Mean± SD 
B.T. 
Mean± SD 
A.T. 
Diff. Of mean  
± S.D. 
Error of 
difference 
 t 
value 
 P 
Value 
S.G.O.T. 313.40 ± 262.72 65.033 ± 32.180 248.37 ± 233.43  42.618 5.828 <0.0001 
S.G.P.T. 341.40 ± 273.65 73.867 ± 32.800 267.53 ± 245.10  44.748 5.979 <0.0001 
Sr. Bilirubin 4.343 ± 2.370 1.323 ± 0.7011 3.020 ± 1.949 0.3558 8.488 <0.0001 
Urine Bile Salts  1.867 ± 0.7303 0.6000 ± 0.4983 1.267 ± 0.7849 0.1433 8.839 <0.0001 
Urine Bile 
Pigment 
1.767 ± 0.8584 0.7333 ± 0.5208 1.033 ±0.8899 0.1625 6.360 <0.0001 
Table 4: Showing effect of therapy on Hb and ESR 
Investigation  Mean ± SD 
 B.T. 
Mean ± SD 
A.T. 
Diff. Of mean ± 
S.D. 
Std. Error of 
difference 
 t 
value 
 p 
value 
Haemoglobin 11.267 ±2.447 11.510 ±2.362 -0.2433 ±0.3036 0.05544 4.389 0.0001 
ESR 12.100 ±4.467 11.067 ±3.965 1.033 ±1.829 0.3339 3.095 0.0043 
Table 5: showing effect of therapy on T. Cholesterol and Sr. Triglycerides 
Investigation Mean ± SD 
 B.T. 
Mean ± SD 
 A.T. 
Diff. Of mean 
± S.D. 
 Std. 
Error of 
Difference 
 t 
value 
 P 
Value 
 Total 
Cholesterol 
195.87 ± 20.848 197.62 ± 25.692 -1.753 ± 17.771  3.244 0.5404 0.5930 
 Serum 
Triglycerides 
149.33 ± 32.355 145.43 ± 22.480 3.900 ± 19.869  3.628 1.075 0.2912 
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Assessment of Safety Variables 
In this RFT is included it was done at the beginning and at the end of study. RFT values namely blood 
urea and BUN are within normal limits and difference observed is statistically insignificant but serum 
creatinine level reduced after the treatment so, it is statistically significant. 
Table 6: showing effect of therapy on RFT 
Investigation Mean ± SD 
 B.T. 
Mean ± SD 
 A.T. 
Diff. Of Mean 
± S.D. 
 Std. 
 Error of 
Difference 
 t value  p  
value 
Blood Urea 33.370 ± 5.916 
 
33.188 ± 5.211 
 
0.1817 ± 4.812 
 
 0.8785 
 
0.2068 
 
0.8376 
 
BUN 13.347 ± 3.036 12.793 ± 2.782 0.5533 ± 2.380  0.4346 1.273 0.2130 
Serum 
Creatinine 
0.9833 ± 0.1967 0.9067 ± 0.1741 0.07667 ± 0.1695  0.03096 2.477 0.0193 
Table 7: Showing Total effect of therapy on patients, having 21days follows up according to 
subjective and objective assessment 
Sr. No.  % of relief in signs 
and symptoms 
% of relief in Bio 
laboratory test 
Average 
% 
Remark 
1 80 86.46838407 83.234 Cured 
2 66.66666667 61.8219798 64.244 Markedly Improved 
3 82.60869565 82.45044352 82.53 Cured 
4 100 68.6207162 84.31 Cured 
5 62.5 77.08697593 69.793 Markedly Improved 
6 46.15384615 84.04814886 65.101 Markedly Improved 
7 86.66666667 78.0042396 82.335 Cured 
8 85.71428571 42.43523974 64.075 Markedly Improved 
9 75 72.32155792 73.661 Markedly Improved 
10 71.42857143 72.1505667 71.79 Markedly Improved 
11 83.33333333 56.09104658 69.712 Markedly Improved 
12 80 46.80241327 63.401 Markedly Improved 
13 85.71428571 31.72727273 58.721 Markedly Improved 
14 80 80.17416268 80.087 Cured 
15 81.81818182 55.8454783 68.832 Markedly Improved 
16 56.52173913 74.35547095 65.439 Markedly Improved 
17 88.23529412 78.31933195 83.277 Cured 
18 85.71428571 83.51588265 84.615 Cured 
19 47.36842105 42.93749373 45.153 Improved 
20 86.66666667 71.10684942 78.887 Cured 
21 72.72727273 56.3622194 64.545 Markedly Improved 
22 90 61.1825837 75.591 Cured 
23 83.33333333 65.69699877 74.515 Markedly Improved 
24 87.5 76.88176963 82.191 Cured 
25 88.88888889 63.54700034 76.218 Cured 
26 80 50.50507239 65.253 Markedly Improved 
27 68.42105263 75.12175065 71.771 Markedly Improved 
28 87.5 46.4411796 66.971 Markedly Improved 
29 85.71428571 34.33082707 60.023 Markedly Improved 
30 88.88888889 66.60230198 77.746 Cured 
As per statistical data from above observation table, the total effect of therapy on 30 patients, 12 
cured, 17 markedly improved and 1 patient is improved. 
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Graphical presentation 
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DISCUSSION 
The present study included 30 cases of 
Kamala in OPD and IPD of Hospital, were treated 
with Vasadi Kashaya. Kamala is a Pittapradoshaj 
vikara which lead to cause Vidagdhata of Rakta and 
Mansa Dhatu which leads to Bahupitta Kamala, so 
the treatment of Kamala is Shodhan Chikitsa i.e. 
Virechan also Pittaghna and Pandu Virodhi Chikitsa 
and Shakhashrit Kamala in which vitiated Kapha 
with the help of Vata Dosha make the obstruction to 
flow of Pitta. The line of treatment is mainly to 
remove obstruction by alleviating Kapha Dosha and 
then Pitta Shodhan by means of Virechan and in 
case of Bahupitta Kamala in which drugs act on 
liver as Yakrutottejak and Yakrut Shodhan which 
leads to normal flow of bile. 
As the Vasadi Kashaya is having Tikta Katu 
Rasa, Laghu Ruksha Guna and Vayu Aakash 
Mahabhuta Gunadhikya which leads to  Samprapti-
vighatan. 
While assessing the treatment response all 
routine investigations was done with liver function 
tests, SGOT, SGPT, Sr. bilirubin, Urine bile salts and 
bile pigments were carried out weekly. Sr. alkaline 
phosphatase. CBC, ESR and lipid profile were done 
at the start and at the end of the study. USG of 
abdomen and pelvis was done as per requirement. 
 No major or minor unwanted reactions of 
the drug were observed during the study. 
 SGOT, SGPT, Sr. Bilirubin, urine bile salts and bile 
pigments has shown extremely significant 
results with p value <0.0001. (Table no. 3) 
 Hemoglobin have also shown extremely 
significant results with p value 0.0001. (Table no. 
4) 
 ESR has shown very significant result with p 
value 0.0043. (Table no. 4) 
 Total Cholesterol and Triglycerides level are 
within normal limits before and after the 
treatment there is no significant result with p 
value of cholesterol and triglycerides 0.5930 and 
0.2912 respectively. (Table no. 5) 
 About RFT there was no significant changes 
observed as they are within normal limits before 
and after study. But Serum creatinine level 
reduced after the treatment so, it is significant. 
(Table no. 6) 
While assessing the treatment response 
subjectively patient had shown significant 
symptomatic relief. The relief of the symptoms from 
the disease is as follows. 
Within 1-2 weeks: Aruchi, Avipaka, Chhardi, 
Udarshoola, Daha, Sadan. 
Within 2-3 weeks: Netrapeetata, Twakapitata, 
Peetamutrata, Jwara, Yakritvruddhi. 
The patient who are having symptoms grade score 
3 are improved up to 1. The patient who are having 
symptoms grade score 1 to 2 are improved 
completely at the end of the study. 
Total Effect of Therapy 
As per the statistical data, out of 30 patients, 
12 patients were cured, 17 patients were markedly 
improved while 1 patient was improved. This data 
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clearly indicates that Vasadi Kashaya has significant 
role in Kamala with Madhu Anupan. 
CONCLUSION 
There observed statistically significant relief 
in all symptoms after the administration of drug. It 
is observed that average percentage of relief with 
the Vasadi Kashaya in Kamala was 75.88% and 
neither symptom was worsening during the entire 
study. (Table no.7) 
 SGOT, SGPT, Sr. bilirubin, Urine bile salts and bile 
pigments has shows extremely significant 
results. (Table no.3) 
 Hemoglobin has also shown extremely 
significant results. (Table no. 4) 
 In case of ESR, there are very significant results 
observed. (Table no. 4) 
 Total cholesterol and triglycerides levels are 
within normal limits before and after the 
treatment so, there are no significant results. 
(Table no. 5) 
 About RFT there was no significant changes 
observed as they are within normal limits before 
and after study. But serum creatinine shows 
significant results. (Table no. 6) 
Thus it seems that the significant effect of these 
drugs is a sum of the total of the action of its 
ingredient. During study none of the patient LFT 
values increased neither the patient worsens 
clinically. 
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